{"title":"Effect of a Yoga and Naturopathy-Based Lifestyle Intervention with 9-Month Follow-Up on Lipid Profile in Patients with Hypertension: A Two-Arm Parallel Group Randomized Controlled Trial.","authors":"Prashanth Shetty, Sujatha Kannarpady Janardhana, Mooventhan Aruchunan, Nandeesh Nanjangud Subbanna, Jyotsna Kamalet Jayasingh, Ashwin Vontikoppal Prakash","doi":"10.1159/000543024","DOIUrl":"10.1159/000543024","url":null,"abstract":"<p><strong>Introduction: </strong>Hypertension is recognized as a modifiable risk factor for cardiovascular diseases, alongside dyslipidemia. Studies have revealed that between 15 and 31% of individuals have both hypertension and dyslipidemia. However, emerging evidence suggests that natural therapies and yoga can help manage mild increases in blood pressure. This study aimed to evaluate the impact of yogic and naturopathy treatments on lipid profiles in hypertensive patients, thereby contributing to the existing literature.</p><p><strong>Materials and methods: </strong>A randomized controlled experiment was conducted, involving 262 hypertensive patients randomly assigned to either the study group (SG) or control group (CG). The SG, consisting of 131 individuals, received yoga and naturopathic treatments for 10 days, while the CG (n = 131) did not. The lipid profile was measured at the beginning and end of the 10 days, and they were followed up and reassessed after 9 months.</p><p><strong>Results: </strong>The study involved a total of 262 individuals, with 111 in the SG and 125 in the CG. After the 10-day intervention period, the SG showed significant reductions in total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, very low-density lipoprotein, apolipoprotein-A (Apo-A), apolipoprotein-B (Apo-B), and lipoprotein-A (Lp-A) (p < 0.001) compared to the CG. Also, the change was observed after 9 months in Apo-A, Apo-B, and Lp-A significantly (p < 0.001).</p><p><strong>Conclusion: </strong>These findings underscore the potential of naturopathic and yogic interventions in improving lipid profiles in hypertensive patients, thereby contributing to the current literature. In conjunction with conventional management, these specific interventions could be considered as a safer form of complementary therapy in the treatment of dyslipidemia among hypertensive patients. Thus, these findings hold promise for the integration of naturopathic and yogic therapies in the standard care of hypertensive patients.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"37-44"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy and Safety of GutGard® in Managing Gastroesophageal Reflux-Related Symptoms: A Phase III, Single-Centre, Double-Blind, Randomized Placebo-Controlled Trial.","authors":"Jeffrey Pradeep Raj, Unnati Saxena, Mahesh Namdeo Belhekar, Ambika Mamde, Harish Darak, Shwetal Pawar","doi":"10.1159/000543367","DOIUrl":"10.1159/000543367","url":null,"abstract":"<p><strong>Introduction: </strong>Liquorice (Glycyrrhiza glabra) is a traditional herbal remedy with various pharmacological activities mainly used for digestive and respiratory ailments. GutGard® is a flavonoid-rich, deglycyrrhizinated liquorice root extract and is standardized to glabridin (≥3.5% w/w), and others viz., glabrol, eicosanyl caffeate, docosyl caffeate, and total flavonoids (≥10% w/w) with glycyrrhizin (≤3.0% w/w) as glycyrrhizin causes electrolyte imbalance, hypertension, and water retention. Hence, the objective of the current study was to assess the efficacy, safety, and tolerability of GutGard® in managing gastroesophageal reflux (GER)-related symptoms when compared to placebo.</p><p><strong>Methods: </strong>It was a double-blind, parallel group, randomized, placebo-controlled trial with participants randomized in a 1:1 ratio to either the placebo group or GutGard® group. The duration of the interventions/treatment was for 28 days and the follow-up visits were done at day 7, day 14, day 28, and day 35. A telephonic follow-up was also done on day 21. The primary outcome measures studied was the change in the Gastroesophageal Reflux Disease-Health-Related Quality of Life and the Gastroesophageal Reflux Disease Symptom Assessment Scale.</p><p><strong>Results: </strong>We screened a total of n = 296 participants and enrolled n = 200 participants and obtained written, informed consent from them. Participants in the GutGard® group reported a significantly better quality of life at the end of the intervention period (p = 0.014). They also reported earlier resolution of symptoms of GER as against the placebo group, especially the symptoms of heartburn (p = 0.017 on day 14 and p = 0.005 on day 28) and regurgitation (p = 0.025 on day 7, p = 0.029 on day 14, and p = 0.022 on day 28).</p><p><strong>Conclusions: </strong>The GutGard® group showed better and earlier resolution (within 2 weeks) of symptoms of GER as against the placebo group, especially heartburn and regurgitation.</p><p><strong>Introduction: </strong>Liquorice (Glycyrrhiza glabra) is a traditional herbal remedy with various pharmacological activities mainly used for digestive and respiratory ailments. GutGard® is a flavonoid-rich, deglycyrrhizinated liquorice root extract and is standardized to glabridin (≥3.5% w/w), and others viz., glabrol, eicosanyl caffeate, docosyl caffeate, and total flavonoids (≥10% w/w) with glycyrrhizin (≤3.0% w/w) as glycyrrhizin causes electrolyte imbalance, hypertension, and water retention. Hence, the objective of the current study was to assess the efficacy, safety, and tolerability of GutGard® in managing gastroesophageal reflux (GER)-related symptoms when compared to placebo.</p><p><strong>Methods: </strong>It was a double-blind, parallel group, randomized, placebo-controlled trial with participants randomized in a 1:1 ratio to either the placebo group or GutGard® group. The duration of the interventions/treatment was for 28 days and the fo","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"26-36"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143390410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Roja Varanasi, Rupali Bhalerao, Paul Sumithran, Kiranmayee G Rompicherla, Pramodji Singh, Sunil S Ramteke, D Karthikeyan, Dubashi Ramesh, Bhuvaneswari Subbarayalu, Shraddha Chauhan, Jayakrishnan Venugopal, Shravani Kampilli, Ajay Meena, Arvind Kumar, Viqar Ahmed Siddiqui, Praveen Oberai, Raj K Manchanda
{"title":"A Comparative Randomized Controlled Trial of Homeopathy versus Allopathy in Acute Otitis Media and Its Recurrence in Children.","authors":"Roja Varanasi, Rupali Bhalerao, Paul Sumithran, Kiranmayee G Rompicherla, Pramodji Singh, Sunil S Ramteke, D Karthikeyan, Dubashi Ramesh, Bhuvaneswari Subbarayalu, Shraddha Chauhan, Jayakrishnan Venugopal, Shravani Kampilli, Ajay Meena, Arvind Kumar, Viqar Ahmed Siddiqui, Praveen Oberai, Raj K Manchanda","doi":"10.1159/000542800","DOIUrl":"10.1159/000542800","url":null,"abstract":"<p><strong>Objective: </strong>This study evaluates the efficacy of homeopathic treatment for acute otitis media (AOM) in children, comparing outcomes to standard allopathic treatments. Building on promising pilot study results that suggested homeopathy's non-inferiority, this multicenter trial aimed to validate these findings and assess their broader clinical applicability.</p><p><strong>Method: </strong>This open-label, randomized controlled trial was conducted on children (aged 02 to 12 years), suffering from AOM. Primary outcome was changes in Acute Otitis Media-Severity of Symptoms (AOM-SOS) scale and Tympanic Membrane Examination Scale (TMES) over 21 days and time to improvement in pain through Faces Pain Scale-Revised (FPS-R) over 10 days. The secondary outcomes were the need for antibiotics during acute AOM and the recurrence over 12 months.</p><p><strong>Results: </strong>Intention-to-treat analysis was carried out on 222 children: homeopathy (n = 116) (H group), allopathy (n = 106) (A group). Statistically significant reduction in AOM-SOS+TMES score in H group compared to A group was observed at time point day 3 (mean diff.±SE: 1.67 ± 0.47; 95% CI: 0.75 to 2.59; p = 0.001) and at day 7 (mean diff.±SE: 1.22 ± 0.56; 95% CI: 0.13 to 2.31, p = 0.028) favored homeopathy. However, the median time for FPS-R score to become zero by day 10 (H = 3 days, A = 4 days) was statistically insignificant (p = 0.29). None of the children in the H group required antibiotics, whereas it was required in 14 children (12.4%) in A group.</p><p><strong>Conclusion: </strong>Homeopathic treatment helped in managing AOM in children similar to that of allopathic treatment. Homeopathy can be a safe treatment approach in managing this condition. Further blinded studies are warranted.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"110-121"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143045791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katharina Gaertner, Robert G Hahn, Radmila Razlog, Frauke Musial, Stephan Baumgartner, Martin Loef, Harald Walach
{"title":"Critical Appraisal Tool for Homeopathic Intervention Studies: CATHIS.","authors":"Katharina Gaertner, Robert G Hahn, Radmila Razlog, Frauke Musial, Stephan Baumgartner, Martin Loef, Harald Walach","doi":"10.1159/000542920","DOIUrl":"10.1159/000542920","url":null,"abstract":"<p><strong>Background: </strong>The quality of homeopathic research studies is controversially discussed. In order to improve, the overall assessment of homeopathic studies and subsequently facilitate evidence-based clinical decision-making, we aimed to combine methodological tools for scientific rigor with tools for external and model validity into one global tool.</p><p><strong>Method: </strong>Against the background of previous literature and the results of a preparatory survey, a first draft of a potential overarching tool was presented to an expert panel. Then, Delphi feedback rounds were conducted to elicit responses on the feasibility. The resulting preliminary tool was pilot-tested by five research experts on five randomly selected studies. After further optimization, another five studies were assessed by the same experts and another three experts tested the second version. The ratings were tested for interrater-reliability using Gwet's AC2.</p><p><strong>Results: </strong>The appraisal tool comprises four domains. These are (1) the assessment of risk-of-bias using the Cochrane Tool, (2) the studies' credibility including the CONSORT statement and its extension on homeopathy, (3) the study interventions' coherence with homeopathic textbooks and previous research, and (4) the studies' clinical relevance. Each domain is assessed using a point system, which is then added up to an overall score. The instrument was evaluated as useful and \"easy to apply\" by the raters. The interrater reliability was 0.81 (95% CI 0.75-0.88) for five raters, and 0.64 (95% CI 0.49-0.79) for additional three raters in round 2, signifying good to moderate interrater reliability.</p><p><strong>Conclusion: </strong>We have developed an applicable and reliable assessment tool for homeopathic intervention studies. Using it in systematic reviews and meta-analyses will increase their scientific value.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"195-204"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143406216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eunbyul Cho, Hui Yan Zhao, Purumea Jun, Jung-Hee Jang
{"title":"Efficacy of Combined Herbal and Western Medicine Based on Traditional Chinese Medicine for Mild Cognitive Impairment and Dementia in Parkinson's Disease: A Systematic Review and Meta-Analysis.","authors":"Eunbyul Cho, Hui Yan Zhao, Purumea Jun, Jung-Hee Jang","doi":"10.1159/000545937","DOIUrl":"10.1159/000545937","url":null,"abstract":"<p><strong>Introduction: </strong>This systematic review aimed to assess the clinical evidence supporting the combination of syndrome differentiation (SD)-based herbal medicine (HM) and Western medicine (WM) in treating Parkinson's disease (PD)-mild cognitive impairment (PD-MCI) and -dementia (PDD).</p><p><strong>Methods: </strong>Ten electronic bibliographic databases were searched from inception to March 4, 2024, for randomized controlled trials (RCTs) comparing SD-based HM plus conventional therapies with conventional therapies alone for PD-MCI and PDD. Two authors independently screened and selected studies and extracted data related to trial quality, characteristics, and results. The mean difference (MD) was used to analyze continuous variables, and meta-analysis was performed using Reviewer Manager 5.4 software. The risk of bias was assessed using the Cochrane Risk of Bias Tool.</p><p><strong>Results: </strong>For the 15 articles selected for review, 12 trials were included in the meta-analysis: 9 comprising 688 patients with PD-MCI and 3 comprising 264 patients with PDD and with a type of SD, such as \"blood stasis and stirring wind\" or \"deficiency of the liver-kidney.\" The meta-analysis showed significant differences favoring HM plus WM with respect to the Montreal Cognitive Assessment score for PD-MCI (MD = 2.30, 95% confidence interval [CI; 1.40, 3.19]; p < 0.00001, I2 = 76%) and PDD (MD = 3.14, 95% CI [0.48, 5.81]; p = 0.02, I2 = 82%) compared with WM alone. Improvement of cognitive impairment treated using \"deficiency of the liver-kidney\" SD-based HM plus WM in PD-MCI was more beneficial than that treated using WM alone.</p><p><strong>Conclusions: </strong>SD-based HM may serve as an adjunctive treatment for PD-MCI and PDD, improving cognitive function and alleviating PD symptoms. No severe adverse event was observed in the HM plus WM group, suggesting that HM may be safe for patients with cognitive impairment in PD. However, evidence regarding the efficacy of HM based on SD for PD-MCI and PDD is of poor quality, and all studies were conducted in China. Thus, and rigorous, multicenter, and international RCTs are required.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"244-259"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Effect of Acupoint Hot Compress on Postpartum Depressive Symptoms: A Secondary Analysis of a Randomized Controlled Trial.","authors":"Yan Wu, Yuhang Zhu, Fangfang Wang, Fan Qu","doi":"10.1159/000543477","DOIUrl":"10.1159/000543477","url":null,"abstract":"<p><strong>Introduction: </strong>Postpartum depressive symptoms (PDS) are common in women after delivery and often progress to postpartum depression (PPD). This secondary analysis aimed to evaluate the effect of acupoint hot compress in patients with different PPD risks.</p><p><strong>Methods: </strong>We conducted a secondary analysis of data from a multicenter randomized controlled trial involving 1,085 participants. Of these, 537 received acupoint hot compress treatment, while 548 received routine postpartum care. Participants were categorized into two groups based on Edinburgh Postnatal Depression Scale (EPDS) scores measured 76.5 h after delivery. Baseline demographic and clinical characteristics were compared, and logistic regression models were used to assess the association between acupoint hot compress and PDS. Subgroup analyses were used to determine the effect of acupoint hot compress on participants with different PPD risks.</p><p><strong>Results: </strong>Among the 1,085 participants, 866 were in the low-risk PPD group (EPDS score <9), and 219 in the high-risk PPD group (EPDS score ≥9). Educational level, labor induction, postpartum uterine contraction pain intensity, sleep and appetite during pregnancy significantly impacted PDS. Acupoint hot compress significantly improved PDS after vaginal delivery, particularly in high-risk PPD patients with lower educational levels, abnormal pregnancy appetite or sleep, and serve postpartum uterine contraction pain.</p><p><strong>Conclusion: </strong>Acupoint hot compress is an effective, non-invasive intervention with minimal side effects for improving PDS.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"101-109"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11991744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Randomized Controlled Crossover Trial to Determine the Effects of Three Nostril-Regulated Breathing Practices on Attention and Mood.","authors":"Kumar Gandharva, Sachin Kumar Sharma, Acharya Balkrishna, Shirley Telles","doi":"10.1159/000543934","DOIUrl":"10.1159/000543934","url":null,"abstract":"<p><strong>Background: </strong>Previous studies on nostril-regulated breathing have contrasting findings attributed to lack of controls or not taking into account baseline nostril patency. This randomized crossover study on the effects of three nostril-regulated yoga breathing practices and two controls on mood states and attention attempted to address these issues.</p><p><strong>Materials and methods: </strong>Forty-five participants between 20 and 45 years (group mean age ± SD; 24.3 ± 3.8 years; M:F: 23:22) were assessed in five sessions in random order on five separate days. Nostril patency-recorded pre-interventions in 225 sessions showed right nostril dominant at rest (RNDR) in 136 and left nostril dominant at rest (LNDR) in 89 sessions. The sessions were (i) SAV or right uninostril breathing, (ii) CAV or left uninostril breathing, (iii) AV or alternate nostril yoga breathing, (iv) breath awareness, and (v) quiet seated rest (QS). The practices were for 15 min each. Nostril patency was recorded pre, and Brief Mood Introspection Scale (BMIS), Global Vigor and Affect Scale (GVAS), and Six-Letter Cancellation Test (SLCT) were recorded pre- and post-each session. Data analysis used general linear mixed model analysis, with fixed effects of states (pre and post), sessions, and baseline nostril dominance (right or left).</p><p><strong>Results: </strong>A significant interaction of sessions, states, and nostril dominance at baseline was observed for total global affect (F9,396.194 = 2.871, p = 0.003) which increased after SAV, CAV, AV, and QS in participants' RNDR (padj < 0.05 in all cases). A significant main effect of states was observed followed by significant post hoc pairwise comparison in RNDR for (i) pleasant mood after SAV, CAV, AV, and QS, (ii) positive mood after SAV and AV, (iii) global vigor (GV) after SAV, CAV, AV, and QS, and (iv) a decrease in negative mood after CAV and AV, while the volunteers who had LNDR showed a significant increase in (i) PU after CAV, AV, and QR, (ii) PT after CAV, and (iii) GV after CAV and QS.</p><p><strong>Conclusion: </strong>Nostril dominance pre-intervention appears to influence the effects of nostril-regulated yoga breathing practices.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"205-213"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michelle Goodrick, Eleazar Samuel Kolosovas-Machuca, Edgar Guevara
{"title":"Yoga Asana Increases Prefrontal Cortex Activity and Reduces Resting-State Functional Connectivity.","authors":"Michelle Goodrick, Eleazar Samuel Kolosovas-Machuca, Edgar Guevara","doi":"10.1159/000545381","DOIUrl":"10.1159/000545381","url":null,"abstract":"<p><strong>Introduction: </strong>Various aspects of yoga have been researched for their psychological benefits, yet the neurological mechanisms underlying physical yoga postures (asana) remain inadequately explored due to limitations in prior neuroimaging techniques. The prefrontal cortex (PFC) has been established as an important region of interest concerning psychological health. Therefore, this study aimed to characterize changes in the PFC before, during, and after asana by applying the functional near-infrared spectroscopy (fNIRS) mobile neuroimaging technique.</p><p><strong>Methods: </strong>Twenty-seven healthy adults completed two 6-min, task-independent resting states before and after a 23-min asana routine. With the fNIRS device positioned on the frontal region of the skull, PFC activity was measured during each asana and resting state. The block design involved alternating between three active postures and one control posture. Each active posture was performed for 30 s and repeated 8 times, while the control posture was held during inter-trial intervals lasting 25-30 s. Across the session, this block design resulted in a total of 24 active blocks (8 repetitions of each active posture) and 25 baseline blocks (control posture intervals).</p><p><strong>Results: </strong>All three active asanas significantly increased PFC activity versus baseline, particularly in the right PFC. Furthermore, analysis of short-term changes in resting-state functional connectivity (rsFC) revealed a significant decrease, primarily in the left medial PFC, a key region of the default mode network (DMN), an area known to exhibit heightened activity in individuals suffering from depression and anxiety.</p><p><strong>Conclusion: </strong>This study provides neurological insight into the effects of yoga asana and supports fNIRS for assessing movement-based practices in real-world settings.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"214-223"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"What a Study Is about Should Be Clear.","authors":"Axel Wiebrecht","doi":"10.1159/000539409","DOIUrl":"10.1159/000539409","url":null,"abstract":"","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"94-95"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}